… extracellular vesicles (EVs) are considered a promising option to exploit mesenchymal stem
cells’ (MSCs) properties to address knee osteoarthritis (… approaches in the treatment of OA …

… ’ study, effective treatment is rare for this chronic disease. Extracellular vesicles (EVs),
including exosomes, microvesicles, and apoptosis bodies, are nano-sized vesicles with a cargo …

… Mesenchymal stem cell-derived small extracellular vesicles (MSC-sEVs) possess a great
therapeutical potential for osteoarthritis (OA) treatment. However, the steric and electrostatic …

… single molecules and/or packaged within extracellular vesicles (EVs), thereby contributing …
EVs (MSC-EVs) are promising treatments for OA, exerting pleiotropic functions by producing a …

… osteoarthritis (OA). As regulatory molecules, microRNAs (miRNAs) can be released from
secretory cells and delivered to recipient cells through extracellular vesicles … the EV-treated rats. …

… characteristics of EVS in the treatment of OA. Characteristics of extracellular vesicles …
Despite the advantages and beneficial effects of EVs in the treatment of OA, there are still some …

… Several miRs showed distinct profiles when we compared young mice treated with drug
with vehicle-treated controls. Levels of mouse miR-92a-3p (mmu-miR-92a-3p), -186-5p, and -…

… for cartilage tissue regeneration or treatment of osteoarthritis. A few major themes emerge
… to assess treatment efficacy for cartilage regeneration, followed by an osteoarthritis model …

… Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles (MSC-EVs)
hold promise as a disease modifying treatment in osteoarthritis (OA). Obesity, and its …

… Osteoarthritis (OA) is the most common disabling joint disease with no effective disease
modifying drugs. Extracellular vesicles … In this study, we demonstrated that extracellular vesicles …